pharmtech.com

International Women’s Day 2025: Improving Innovation in Industry

Gender diversity and equality in leadership positions have been shown to improve profitability and return on equity through greater innovation and more creative solutions.

Recent Videos

International Women’s Day 2025: A Promising Future for Gender Diversity in PharmaBehind the Headlines Episode 12–Cell and Gene Therapies, New Genomics Tools, and Recent PartnershipsIndustry Outlook 2025: From the Perspective of a Software DeveloperIndustry Outlook 2025: Interesting Relations and Detailed Discussions on DataAsk the Expert: Complying with 21 CFR 211.110Industry Outlook 2025: Personalizing Precision Medicine and Adopting AIBehind the Headlines Episode 11–GLP-1 Patent Expiry, Recent Acquisitions, and Indirect Costs CappingInternational Day of Women and Girls in Science: Fostering STEM Careers for Women

Related Content

PharmTech News

|

Business

|

Business News

|

Industry News

Adragos Pharma Completes Liquid Filling Line Installation in Germany

Patrick Lavery

March 7th 2025ArticleThe €4 million (US$4.3 million) project is current good manufacturing practice compliant, and includes an accompanying cartoning machine.

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy

November 13th 2023PodcastIn this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

FDA Makes Class-Wide Labeling Changes to Testosterone Products

Patrick Lavery

March 6th 2025ArticleThe alterations are the result of an agency review of findings from a clinical trial, and data from required postmarket studies.

Drug Solutions Podcast: Examining the State of Biopharma Investment

Grant Playter

June 6th 2023PodcastIn this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.

CordenPharma Selects Switzerland Site for Peptide Manufacturing Facility

Patrick Lavery

March 5th 2025ArticleThe company first announced its intention to build the state-of-the-art facility as part of a €900 million investment in July 2024.

Nelson Labs Launches Rapid Sterility Testing, Cutting Incubation Times

Patrick Lavery

March 4th 2025ArticleThe company now performs product-sterility testing through rapid microbiological methods at two laboratory sites in the United States and one in Germany.

Read full news in source page